1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Consumption 2016-2026 2.1.2 Inhalation Sevoflurane Anaesthetic Agent Consumption CAGR by Region 2.2 Inhalation Sevoflurane Anaesthetic Agent Segment by Type 2.2.1 Generic Drug 2.2.2 Brand Drug 2.3 Inhalation Sevoflurane Anaesthetic Agent Sales by Type 2.3.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2021) 2.3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue and Market Share by Type (2016-2021) 2.3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Type (2016-2021) 2.4 Inhalation Sevoflurane Anaesthetic Agent Segment by Application 2.4.1 Chidren 2.4.2 Adult 2.5 Inhalation Sevoflurane Anaesthetic Agent Sales by Application 2.5.1 Global Inhalation Sevoflurane Anaesthetic Agent Sale Market Share by Application (2016-2021) 2.5.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue and Market Share by Application (2016-2021) 2.5.3 Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Application (2016-2021) 3 Global Inhalation Sevoflurane Anaesthetic Agent by Company 3.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Company 3.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Company (2019-2021) 3.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Company (2019-2021) 3.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Company 3.2.1 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Company (2019-2021) 3.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Company (2019-2021) 3.3 Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Company 3.4 Global Manufacturers Inhalation Sevoflurane Anaesthetic Agent Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Inhalation Sevoflurane Anaesthetic Agent Product Location Distribution 3.4.2 Players Inhalation Sevoflurane Anaesthetic Agent Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 Inhalation Sevoflurane Anaesthetic Agent by Region 4.1 Global Inhalation Sevoflurane Anaesthetic Agent by Region 4.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region 4.1.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region 4.2 Americas Inhalation Sevoflurane Anaesthetic Agent Sales Growth 4.3 APAC Inhalation Sevoflurane Anaesthetic Agent Sales Growth 4.4 Europe Inhalation Sevoflurane Anaesthetic Agent Sales Growth 4.5 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Growth 5 Americas 5.1 Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Country 5.1.1 Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021) 5.1.2 Americas Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021) 5.2 Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Type 5.3 Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Region 6.1.1 APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2016-2021) 6.1.2 APAC Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2016-2021) 6.2 APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Type 6.3 APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Application 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Inhalation Sevoflurane Anaesthetic Agent by Country 7.1.1 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021) 7.1.2 Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021) 7.2 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type 7.3 Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent by Country 8.1.1 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021) 8.1.2 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021) 8.2 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type 8.3 Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Country 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Marketing, Distributors and Customer 10.1 Sales Channel 10.1.1 Direct Channels 10.1.2 Indirect Channels 10.2 Inhalation Sevoflurane Anaesthetic Agent Distributors 10.3 Inhalation Sevoflurane Anaesthetic Agent Customer 11 Global Inhalation Sevoflurane Anaesthetic Agent Market Forecast 11.1 Global Inhalation Sevoflurane Anaesthetic Agent Forecast by Region 11.1.1 Global Inhalation Sevoflurane Anaesthetic Agent Forecast by Regions (2021-2026) 11.2.2 Global Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Regions (2021-2026) 11.2 Americas Forecast by Country 11.3 APAC Forecast by Region 11.4 Europe Forecast by Country 11.5 Middle East & Africa Forecast by Country 11.6 Global Inhalation Sevoflurane Anaesthetic Agent Forecast by Type 11.7 Global Inhalation Sevoflurane Anaesthetic Agent Forecast by Application 12 Key Players Analysis 12.1 AbbVie 12.1.1 AbbVie Company Information 12.1.2 AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Offered 12.1.3 AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2019-2021) 12.1.4 AbbVie Main Business Overview 12.1.5 AbbVie Latest Developments 12.2 Baxter 12.2.1 Baxter Company Information 12.2.2 Baxter Inhalation Sevoflurane Anaesthetic Agent Product Offered 12.2.3 Baxter Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2019-2021) 12.2.4 Baxter Main Business Overview 12.2.5 Baxter Latest Developments 12.3 Maruishi Pharmaceutical 12.3.1 Maruishi Pharmaceutical Company Information 12.3.2 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Offered 12.3.3 Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2019-2021) 12.3.4 Maruishi Pharmaceutical Main Business Overview 12.3.5 Maruishi Pharmaceutical Latest Developments 12.4 Jiangsu Hengrui 12.4.1 Jiangsu Hengrui Company Information 12.4.2 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Offered 12.4.3 Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2019-2021) 12.4.4 Jiangsu Hengrui Main Business Overview 12.4.5 Jiangsu Hengrui Latest Developments 12.5 Lunan Pharmaceutical 12.5.1 Lunan Pharmaceutical Company Information 12.5.2 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Offered 12.5.3 Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales, Revenue, Price and Gross Margin (2019-2021) 12.5.4 Lunan Pharmaceutical Main Business Overview 12.5.5 Lunan Pharmaceutical Latest Developments 13 Research Findings and Conclusion

List of Tables Table 1. Inhalation Sevoflurane Anaesthetic Agent Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Generic Drug Table 3. Major Players of Brand Drug Table 4. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021) & (K Units) Table 5. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2021) Table 6. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Type (2016-2021) & ($ million) Table 7. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2016-2021) Table 8. Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Type (2016-2021) Table 9. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021) & (K Units) Table 10. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2021) Table 11. Global Inhalation Sevoflurane Anaesthetic Agent Value by Application (2016-2021) Table 12. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application (2016-2021) Table 13. Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Application (2016-2021) Table 14. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Company (2019-2021) & (K Units) Table 15. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Company (2019-2021) Table 16. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Company (2019-2021) ($ Millions) Table 17. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Company (2019-2021) Table 18. Global Inhalation Sevoflurane Anaesthetic Agent Sale Price by Company (2019-2021) Table 19. Key Manufacturers Inhalation Sevoflurane Anaesthetic Agent Producing Area Distribution and Sales Area Table 20. Players Inhalation Sevoflurane Anaesthetic Agent Products Offered Table 21. Inhalation Sevoflurane Anaesthetic Agent Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 22. New Products and Potential Entrants Table 23. Mergers & Acquisitions, Expansion Table 24. Global Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2016-2021) (K Units) Table 25. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2016-2021) Table 26. Global Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2016-2021) & ($ Millions) Table 27. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2016-2021) Table 28. Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021) & (K Units) Table 29. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2016-2021) Table 30. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021) & ($ Millions) Table 31. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2016-2021) Table 32. Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021) & (K Units) Table 33. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2021) Table 34. Americas Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021) & (K Units) Table 35. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2021) Table 36. APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2016-2021) & (K Units) Table 37. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region (2016-2021) Table 38. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue by Region (2016-2021) & ($ Millions) Table 39. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region (2016-2021) Table 40. APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021) & (K Units) Table 41. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2021) Table 42. APAC Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021) & (K Units) Table 43. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2021) Table 44. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021) & (K Units) Table 45. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2016-2021) Table 46. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021) & ($ Millions) Table 47. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2016-2021) Table 48. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021) & (K Units) Table 49. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2021) Table 50. Europe Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021) & (K Units) Table 51. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2021) Table 52. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Country (2016-2021) & (K Units) Table 53. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country (2016-2021) Table 54. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue by Country (2016-2021) & ($ Millions) Table 55. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country (2016-2021) Table 56. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Type (2016-2021) & (K Units) Table 57. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type (2016-2021) Table 58. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales by Application (2016-2021) & (K Units) Table 59. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2021) Table 60. Key and Potential Regions of Inhalation Sevoflurane Anaesthetic Agent Table 61. Key Application and Potential Industries of Inhalation Sevoflurane Anaesthetic Agent Table 62. Key Challenges of Inhalation Sevoflurane Anaesthetic Agent Table 63. Key Trends of Inhalation Sevoflurane Anaesthetic Agent Table 64. Inhalation Sevoflurane Anaesthetic Agent Distributors List Table 65. Inhalation Sevoflurane Anaesthetic Agent Customer List Table 66. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Region (2021-2026) & (K Units) Table 67. Global Inhalation Sevoflurane Anaesthetic Agent Consumption Market Forecast by Region Table 68. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Region (2021-2026) & ($ millions) Table 69. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share Forecast by Region (2021-2026) Table 70. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2021-2026) & (K Units) Table 71. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Country (2021-2026) & ($ millions) Table 72. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Region (2021-2026) & (K Units) Table 73. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Region (2021-2026) & ($ millions) Table 74. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2021-2026) & (K Units) Table 75. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Country (2021-2026) & ($ millions) Table 76. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Country (2021-2026) & (K Units) Table 77. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Country (2021-2026) & ($ millions) Table 78. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Type (2021-2026) & (K Units) Table 79. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Type (2021-2026) Table 80. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Type (2021-2026) & ($ Millions) Table 81. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share Forecast by Type (2021-2026) Table 82. Global Inhalation Sevoflurane Anaesthetic Agent Sales Forecast by Application (2021-2026) & (K Units) Table 83. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share Forecast by Application (2021-2026) Table 84. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Forecast by Application (2021-2026) & ($ Millions) Table 85. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share Forecast by Application (2021-2026) Table 86. AbbVie Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors Table 87. AbbVie Inhalation Sevoflurane Anaesthetic Agent Product Offered Table 88. AbbVie Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 89. AbbVie Main Business Table 90. AbbVie Latest Developments Table 91. Baxter Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors Table 92. Baxter Inhalation Sevoflurane Anaesthetic Agent Product Offered Table 93. Baxter Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 94. Baxter Main Business Table 95. Baxter Latest Developments Table 96. Maruishi Pharmaceutical Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors Table 97. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Offered Table 98. Maruishi Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 99. Maruishi Pharmaceutical Main Business Table 100. Maruishi Pharmaceutical Latest Developments Table 101. Jiangsu Hengrui Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors Table 102. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Product Offered Table 103. Jiangsu Hengrui Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 104. Jiangsu Hengrui Main Business Table 105. Jiangsu Hengrui Latest Developments Table 106. Lunan Pharmaceutical Basic Information, Inhalation Sevoflurane Anaesthetic Agent Manufacturing Base, Sales Area and Its Competitors Table 107. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Product Offered Table 108. Lunan Pharmaceutical Inhalation Sevoflurane Anaesthetic Agent Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2021E) Table 109. Lunan Pharmaceutical Main Business Table 110. Lunan Pharmaceutical Latest Developments List of Figures Figure 1. Picture of Inhalation Sevoflurane Anaesthetic Agent Figure 2. Inhalation Sevoflurane Anaesthetic Agent Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Inhalation Sevoflurane Anaesthetic Agent Sales Growth Rate 2016-2026 (K Units) Figure 7. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Inhalation Sevoflurane Anaesthetic Agent Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Generic Drug Figure 10. Product Picture of Brand Drug Figure 11. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type in 2020 Figure 12. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Type (2016-2021) Figure 13. Inhalation Sevoflurane Anaesthetic Agent Consumed in Chidren Figure 14. Global Inhalation Sevoflurane Anaesthetic Agent Market: Chidren (2016-2021) & (K Units) Figure 15. Inhalation Sevoflurane Anaesthetic Agent Consumed in Adult Figure 16. Global Inhalation Sevoflurane Anaesthetic Agent Market: Adult (2016-2021) & (K Units) Figure 17. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application (2016-2021) Figure 18. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Application in 2020 Figure 19. Inhalation Sevoflurane Anaesthetic Agent Revenue Market by Company in 2020 ($ Million) Figure 20. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Company in 2020 Figure 21. Global Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Regions (2016-2021) Figure 22. Global Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Region in 2020 Figure 23. Americas Inhalation Sevoflurane Anaesthetic Agent Sales 2016-2021 (K Units) Figure 24. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue 2016-2021 ($ Millions) Figure 25. APAC Inhalation Sevoflurane Anaesthetic Agent Sales 2016-2021 (K Units) Figure 26. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue 2016-2021 ($ Millions) Figure 27. Europe Inhalation Sevoflurane Anaesthetic Agent Sales 2016-2021 (K Units) Figure 28. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue 2016-2021 ($ Millions) Figure 29. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales 2016-2021 (K Units) Figure 30. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue 2016-2021 ($ Millions) Figure 31. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2020 Figure 32. Americas Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country in 2020 Figure 33. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type in 2020 Figure 34. Americas Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application in 2020 Figure 35. United States Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 36. Canada Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 37. Mexico Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 38. Brazil Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 39. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Region in 2020 Figure 40. APAC Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Regions in 2020 Figure 41. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type in 2020 Figure 42. APAC Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application in 2020 Figure 43. China Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 44. Japan Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 45. Korea Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 46. Southeast Asia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 47. India Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 48. Australia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 49. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2020 Figure 50. Europe Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country in 2020 Figure 51. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type in 2020 Figure 52. Europe Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application in 2020 Figure 53. Germany Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 54. France Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 55. UK Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 56. Italy Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 57. Russia Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 58. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Country in 2020 Figure 59. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Market Share by Country in 2020 Figure 60. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Type in 2020 Figure 61. Middle East & Africa Inhalation Sevoflurane Anaesthetic Agent Sales Market Share by Application in 2020 Figure 62. Egypt Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 63. South Africa Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 64. Israel Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 65. Turkey Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 66. GCC Country Inhalation Sevoflurane Anaesthetic Agent Revenue Growth 2016-2021 ($ Millions) Figure 67. Channels of Distribution Figure 68. Distributors Profiles